Extremity osteosarcomas: intraarterial chemotherapy
โ Scribed by Azevedo, I.; Costa, B.; Dinis, J.; Rodrigues, H.; Lopes, M.; Azevedo, C.
- Book ID
- 123219406
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 306 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The role of adjuvant chemotherapy for osteosarcoma has been well defined. Recently, the use of preoperative chemotherapy has been further enhanced by the use of intraarterial cisplatin. The authors describe the use and results of systemic doxorubicin and intraarterial cisplatin as a preoperative reg
Background. Chemotherapy has dramatically improved the rates of cure and survival of patients with localized and metastatic osteosarcoma. Nonetheless, the number of chemotherapeutic agents active against osteosarcoma is limited to doxorubicin, cisplatin, high-dose methotrexate, and ifosfamide. Carbo